Literature DB >> 10754778

Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.

F Fábregues1, J Balasch, M Creus, F Carmona, B Puerto, L Quintó, R Casamitjana, J A Vanrell.   

Abstract

PURPOSE: Our purpose was to determine prospectively, using receiver-operating characteristic (ROC) analysis, whether the ovarian reserve test with hMG could improve the predictive value of a woman's age and basal levels of follicle stimulating hormone (FSH), E2, and inhibin or any combination of them regarding ovarian response and pregnancy rate in IVF treatment following pituitary desensitization.
METHODS: The hMG test was performed within 3 months of IVF treatment in 80 women undergoing the first cycle of IVF and consisted of 2 ampoules of hMG daily for 5 days starting on cycle days 2 to 3. Hormone and ultrasound evaluation was performed on cycle days 2 to 3 and 7 to 8.
RESULTS: The mean age and basal FSH levels were significantly higher in the canceled (n = 28) than in the control (n = 52) group, whereas the basal inhibin level was significantly higher in the latter. Regarding ovarian response, the combination FSH plus inhibin had the better diagnostic accuracy (predictive value of 70%) among basal variables. When post-hMG parameters (alone or in combination) were analyzed, E2 alone, with a 77% diagnostic accuracy, emerged as the best predictive variable of cancellation in IVF cycles. When ROC analysis was used, the area under the ROC curve for E2 post-hMG (diagnostic accuracy of 84.5%) was significantly higher than that for the estimates based on the combination of basal FSH and inhibin (diagnostic accuracy of 71.3%). However, woman's age was the only variable independently associated with pregnancy rate.
CONCLUSIONS: The predictive power of the hMG test of ovarian reserve is better than that of age and basal hormone values (FSH and inhibin) and it is based mainly on the E2 response to hMG treatment. However, given that age is the only predictor of pregnancy and considering the cost and discomfort of the hMG test, the usefulness, if any, of the test in predicting IVF performance in the daily clinical setting remains to be established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754778      PMCID: PMC3455189          DOI: 10.1023/a:1009441812247

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  20 in total

1.  The diagnostic use of gonadotropins.

Authors:  P G McDonough; V B Mahesh; J R Byrd
Journal:  Fertil Steril       Date:  1970-02       Impact factor: 7.329

2.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

3.  Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: correlation with in-vitro fertilization outcome.

Authors:  F Galtier-Dereure; V De Bouard; M C Picto; C Vergnes; C Humeau; J Bringer; B Hedon
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

4.  Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome.

Authors:  K Sharif; M Elgendy; H Lashen; M Afnan
Journal:  Br J Obstet Gynaecol       Date:  1998-01

5.  Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.

Authors:  J Balasch; F Fábregues; M Creus; V Moreno; B Puerto; J Peñarrubia; F Carmona; J A Vanrell
Journal:  Hum Reprod       Date:  1996-11       Impact factor: 6.918

6.  Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

Authors:  D B Seifer; G Lambert-Messerlian; J W Hogan; A C Gardiner; A S Blazar; C A Berk
Journal:  Fertil Steril       Date:  1997-01       Impact factor: 7.329

7.  The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years.

Authors:  J Roest; A M van Heusden; H Mous; G H Zeilmaker; A Verhoeff
Journal:  Fertil Steril       Date:  1996-12       Impact factor: 7.329

8.  Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels.

Authors:  J Farhi; R Homburg; A Ferber; R Orvieto; Z Ben Rafael
Journal:  Hum Reprod       Date:  1997-02       Impact factor: 6.918

9.  Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle.

Authors:  H G Burger; N P Groome; D M Robertson
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program.

Authors:  F Fábregues; J Balasch; M Creus; S Cívico; F Carmona; B Puerto; J A Vanrell
Journal:  Fertil Steril       Date:  1998-07       Impact factor: 7.329

View more
  2 in total

1.  Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation.

Authors:  Y Y Hsieh; C C Chang; H D Tsai
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

2.  Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.

Authors:  Ming-fang Miao; He-feng Huang
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.